OverviewSuggest Edit

Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is developing multiple precision diagnostic products and platforms to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making and, ultimately, patient care.
TypePublic
Founded1983
HQDublin, US
Websitenavidea.com

Latest Updates

Employees (est.) (Mar 2019)14(-26%)
Revenue (FY, 2018)$1.2 M(-35%)
Share Price (Oct 2019)$0.7 (-7%)

Key People/Management at Navidea Biopharmaceuticals

Michael Goldberg

Michael Goldberg

President and Chief Executive Officer

Navidea Biopharmaceuticals Office Locations

Navidea Biopharmaceuticals has an office in Dublin
Dublin, US (HQ)
4995 Bradenton Ave #240
Show all (1)

Navidea Biopharmaceuticals Financials and Metrics

Navidea Biopharmaceuticals Revenue

Embed Graph
View revenue for all periods
Navidea Biopharmaceuticals's revenue was reported to be $1.17 m in FY, 2018
USD

Net income (Q2, 2019)

(2.7m)

EBIT (Q2, 2019)

(2.7m)

Market capitalization (21-Oct-2019)

13.4m

Closing stock price (21-Oct-2019)

0.7

Cash (30-Jun-2019)

5.1m

EV

8.5m
Navidea Biopharmaceuticals's current market capitalization is $13.4 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.1m13.2m22.0m1.8m1.2m

Cost of goods sold

332.8k1.8m2.3m3.7k96.6k

Gross profit

797.8k11.5m19.7m1.8m1.1m

Gross profit Margin, %

71%87%90%100%92%
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

400.4k751.8k1.1m2.3m2.1m2.9m4.0m4.7m5.4m8.5m580.0k611.6k223.7k276.4k542.1k231.5k136.0k

Cost of goods sold

75.4k193.2k270.5k807.9k449.1k332.7k457.6k534.9k560.7k921.8k318.035.4k38.1k6.1k238.0

Gross profit

325.0k558.6k804.2k1.4m1.7m2.5m3.5m4.2m4.8m7.6m276.1k506.7k193.4k129.9k

Gross profit Margin, %

81%74%75%64%79%88%89%89%90%89%100%93%84%95%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

32.9m5.5m7.2m1.5m2.8m3.5m

Accounts Receivable

1.2m816.5k

Inventories

2.2m652.9k1.5m

Current Assets

37.3m8.6m12.6m10.8m13.8m5.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

44.6m26.0m17.5m10.4m4.9m15.8m11.4m5.5m1.2m810.4k13.4m5.6m4.6m817.0k4.7m5.7m1.5m5.1m

Accounts Receivable

157.8k586.7k487.1k1.5m1.2m1.8m1.9m

Inventories

2.0m2.1m1.9m1.1m571.6k1.2m877.2k898.9k769.8k804.9k748.0

Current Assets

47.6m29.5m20.6m14.0m8.0m19.5m15.0m10.0m6.9m9.4m21.7m16.8m15.2m16.2m6.6m7.1m3.2m6.5m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(42.7m)(35.7m)(27.6m)(14.3m)74.9m(16.1m)

Inventories

(1.9m)761.0k136.0k(861.3k)1.5m

Accounts Payable

1.0m(944.8k)290.0k5.4m(6.0m)(430.3k)

Cash From Operating Activities

(35.6m)(29.1m)(19.1m)3.6m59.1m4.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(28.9m)(11.7m)(22.0m)(28.9m)(7.3m)(17.0m)(25.1m)(3.7m)(10.4m)(10.4m)85.6m80.4m79.0m(6.7m)(9.1m)(13.0m)(2.4m)(5.1m)

Depreciation and Amortization

320.1k111.3k235.4k360.7k149.8k299.1k431.4k149.6k267.4k378.8k86.5k161.8k212.1k38.0k75.5k113.1k36.8k73.5k

Inventories

(1.7m)118.5k326.7k573.2k240.5k(355.5k)(83.7k)(246.0k)(116.9k)(195.3k)1.5m1.5m1.5m

Accounts Payable

287.3k3.9k(748.3k)(45.4k)428.5k(119.8k)(178.6k)1.1m3.4m3.2m(3.8m)(5.5m)(5.9m)(154.8k)(401.3k)(239.5k)427.9k248.3k
USDY, 2019

EV/EBIT

-3.2 x

EV/CFO

-2 x

Financial Leverage

2.8 x
Show all financial metrics

Navidea Biopharmaceuticals Online and Social Media Presence

Embed Graph

Navidea Biopharmaceuticals News and Updates

Navidea Biopharmaceuticals Frequently Asked Questions

  • When was Navidea Biopharmaceuticals founded?

    Navidea Biopharmaceuticals was founded in 1983.

  • Who are Navidea Biopharmaceuticals key executives?

    Navidea Biopharmaceuticals's key executives are Michael Goldberg.

  • How many employees does Navidea Biopharmaceuticals have?

    Navidea Biopharmaceuticals has 14 employees.

  • What is Navidea Biopharmaceuticals revenue?

    Latest Navidea Biopharmaceuticals annual revenue is $1.2 m.

  • What is Navidea Biopharmaceuticals revenue per employee?

    Latest Navidea Biopharmaceuticals revenue per employee is $83.5 k.

  • Who are Navidea Biopharmaceuticals competitors?

    Competitors of Navidea Biopharmaceuticals include Adaptive Biotechnologies, Opko Health and Veritas Genetics.

  • Where is Navidea Biopharmaceuticals headquarters?

    Navidea Biopharmaceuticals headquarters is located at 4995 Bradenton Ave #240, Dublin.

  • Where are Navidea Biopharmaceuticals offices?

    Navidea Biopharmaceuticals has an office in Dublin.

  • How many offices does Navidea Biopharmaceuticals have?

    Navidea Biopharmaceuticals has 1 office.